UB Paderborn / Katalog / Suche / in CDI

Working towards personalized anticoagulation management

International journal of cardiology, 2022-10, Vol.364, p.102-102

Nierman, Melchior C.

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial

Circulation (New York, N.Y.), 2024-01, Vol.149 (4), p.279

2024

Link zum Volltext

Verfügbarkeit prüfen

Enhanced identification of familial hypercholesterolemia using central laboratory algorithms

Atherosclerosis, 2024-06, Vol.393, p.117548-117548, Article 117548

2024

Link zum Volltext

Verfügbarkeit prüfen

Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study

Journal of thrombosis and haemostasis, 2022-01, Vol.20 (1), p.92-103

2022

Link zum Volltext

Verfügbarkeit prüfen

The effect of COVID-19 vaccination on anticoagulation stability in adolescents and young adults using vitamin K antagonists

Thrombosis research, 2023-08, Vol.228, p.121-127

2023

Link zum Volltext

Verfügbarkeit prüfen

New risk factors for atherosclerosis and patient risk assessment

Circulation (New York, N.Y.), 2004-06, Vol.109 (23 Suppl 1), p.III15-III19

2004

Link zum Volltext

Verfügbarkeit prüfen

Switching from vitamin K antagonists to direct oral anticoagulants in non‐valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?

Journal of thrombosis and haemostasis, 2022-02, Vol.20 (2), p.339-352

2022

Link zum Volltext

Verfügbarkeit prüfen

The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists

Thrombosis and haemostasis, 2022-03, Vol.122 (3), p.377

2022

Link zum Volltext

Verfügbarkeit prüfen

Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns

Journal of thrombosis and haemostasis, 2020-06, Vol.18 (6), p.1390-1397

2020

Link zum Volltext

Verfügbarkeit prüfen

Intervention to Improve Adherence to Lipid-Lowering Medication and Lipid-Levels in Patients With an Increased Cardiovascular Risk

The American journal of cardiology, 2012-09, Vol.110 (5), p.666-672

2012

Link zum Volltext

Verfügbarkeit prüfen

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis

Research and practice in thrombosis and haemostasis, 2021-10, Vol.5 (7), p.e12597-n/a, Article e12597

2021

Link zum Volltext

Verfügbarkeit prüfen

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants

Research and practice in thrombosis and haemostasis, 2020-05, Vol.4 (4), p.586-593

2020

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation

Arteriosclerosis, thrombosis, and vascular biology, 2006-06, Vol.26 (6), p.1236

2006

Link zum Volltext

Verfügbarkeit prüfen

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial

BMJ open, 2019-12, Vol.9 (12), p.e032488

2019

Link zum Volltext

Verfügbarkeit prüfen

Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia

Journal of lipid research, 2006-10, Vol.47 (10), p.2333-2339

2006

Link zum Volltext

Verfügbarkeit prüfen

Gene therapy for lipoprotein lipase deficiency : Working toward clinical application

Human gene therapy, 2005-11, Vol.16 (11), p.1276-1286

2005

Link zum Volltext

Verfügbarkeit prüfen

Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study

Arteriosclerosis, thrombosis, and vascular biology, 2006-03, Vol.26 (3), p.637

2006

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia

Acta Paediatrica, 2006-11, Vol.95 (11), p.1461-1466

2006

Link zum Volltext

Verfügbarkeit prüfen

Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers

Arteriosclerosis, thrombosis, and vascular biology, 2005-11, Vol.25 (11), p.2410

2005

Link zum Volltext

Verfügbarkeit prüfen

Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance

Metabolism, clinical and experimental, 2005-11, Vol.54 (11), p.1499-1503

2005

Link zum Volltext

Verfügbarkeit prüfen

Finding very high lipoprotein(a): the need for routine assessment

European journal of preventive cardiology, 2022-05, Vol.29 (5), p.769

2022

Link zum Volltext

Verfügbarkeit prüfen

A prospective study investigating the relation between blood‐based biomarkers for Alzheimer’s disease and diagnosis/patient management in primary care: The CANTATE‐PC study

Alzheimer's & dementia, 2023-12, Vol.19 (S14), p.n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients

Arteriosclerosis, thrombosis, and vascular biology, 2008-12, Vol.28 (12), p.2303

2008

Link zum Volltext

Verfügbarkeit prüfen

Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes

Atherosclerosis, 2007-10, Vol.194 (2), p.446-451

2007

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein lipase gene analyses in one Turkish family and three different Chinese families with severe hypertriglyceridaemia: One novel and several established mutations

Journal of inherited metabolic disease, 2006-10, Vol.29 (5), p.686-686

2006

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Working towards personalized anticoagulation management

Safety of Switching From a Vitamin K Antagonist to a Non-Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF Randomized Controlled Trial

Enhanced identification of familial hypercholesterolemia using central laboratory algorithms

Inter‐ and intra‐individual concentrations of direct oral anticoagulants: The KIDOAC study

The effect of COVID-19 vaccination on anticoagulation stability in adolescents and young adults using vitamin K antagonists

New risk factors for atherosclerosis and patient risk assessment

Switching from vitamin K antagonists to direct oral anticoagulants in non‐valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence?

The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists

Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns

Intervention to Improve Adherence to Lipid-Lowering Medication and Lipid-Levels in Patients With an Increased Cardiovascular Risk

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis

Self‐reported therapy adherence and predictors for nonadherence in patients who switched from vitamin K antagonists to direct oral anticoagulants

Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation

Safety of switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulant in frail elderly with atrial fibrillation: rationale and design of the FRAIL-AF randomised controlled trial

Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia

Gene therapy for lipoprotein lipase deficiency : Working toward clinical application

Serum lipoprotein lipase concentration and risk for future coronary artery disease: the EPIC-Norfolk prospective population study

Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolaemia

Enhanced conversion of triglyceride-rich lipoproteins and increased low-density lipoprotein removal in LPLS447X carriers

Carriers of the frequent lipoprotein lipase S447X variant exhibit enhanced postprandial apoprotein B-48 clearance

Finding very high lipoprotein(a): the need for routine assessment

A prospective study investigating the relation between blood‐based biomarkers for Alzheimer’s disease and diagnosis/patient management in primary care: The CANTATE‐PC study

Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients

Enhanced apoB48 metabolism in lipoprotein lipase X447 homozygotes

Lipoprotein lipase gene analyses in one Turkish family and three different Chinese families with severe hypertriglyceridaemia: One novel and several established mutations

Suchergebnisse filtern